Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 1989;20:1059-1064

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dalkara, T.
Right arrow Articles by Zileli, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dalkara, T.
Right arrow Articles by Zileli, T.

Stroke, Vol 20, 1059-1064, Copyright © 1989 by American Heart Association


ARTICLES

Intravenously and iontophoretically administered naloxone reverses ischemic changes in rat hippocampus

T Dalkara, IJ Namer, R Onur and T Zileli
Department of Neurology, Hacettepe University Hospitals, Ankara, Turkey.

Forty rats under urethane anesthesia were subjected to cerebral ischemia by ligation of the right carotid, the right plus the left carotid, or the right carotid plus two vertebral arteries. Ischemia caused three types of changes in the field potential of the right hippocampal CA1 region evoked by fimbrial stimulation: 1) completely reversible deterioration (57% and 16% of the rats with unilateral and bilateral carotid artery ligation, respectively), 2) moderate deterioration (37% and 24% of the rats with unilateral and bilateral carotid artery ligation) and 3) irreversible loss of the evoked activity (6% and 60% of the rats with unilateral and bilateral carotid artery ligation and all the rats subjected to three-vessel occlusion). Naloxone improved the moderate deterioration in 10 of 11 rats (1-3 mg/kg i.v.) and in 15 of 16 (50-150 nA) iontophoretic applications, but naloxone did not restore the lost evoked activity. Intravenous morphine (10 mg/kg) aggravated the ischemic changes, and this effect was reversed by naloxone, while iontophoretic administration of morphine caused only excitation. These findings suggest that naloxone has a favorable effect on cerebral ischemia not severe enough to cause transmission failure. The reversal of ischemic changes by iontophoretic naloxone indicates that its site of action is at the neuronal or microcirculatory level.


This article has been cited by other articles:


Home page
StrokeHome page
T. Dalkara, C. Ayata, M. Demirci, G. Erdemli, and R. Onur
Effects of Cerebral Ischemia on N-Methyl-D-Aspartate and Dihydropyridine-Sensitive Calcium Currents : An Electrophysiological Study in the Rat Hippocampus In Situ
Stroke, January 1, 1996; 27(1): 127 - 133.
[Abstract] [Full Text]